March 2026
The global cell and tissue preservation market size is expected to increase from USD 5.20 billion in 2025 to hit around USD 13.00 billion by 2034, with a CAGR of 8.31%.
June 2026
The global cell cryopreservation market size is valued at USD 1,640.9 million in 2025 and is projected to hit around USD 5,028.90 million by 2035 with a CAGR of 11.85%.
June 2026
The US cell and gene therapy market size was evaluated at USD 4.09 billion in 2025 and is predicted to hit around USD 20.00 billion by 2035, growing at a CAGR of 17.21%.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
April 2026
The global automation, digitization and robotics in cell and gene therapy manufacturing market size was evaluated at USD 950.00 million in 2025 and is predicted to hit around USD 5,275.10 million by 2035, growing at a CAGR of 18.70%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
March 2026
The global extremity tissue expanders market size was evaluated at USD 840.11 million in 2025 and is predicted to hit around USD 2081.98 million by 2035, growing at a CAGR of 9.50%.
December 2025
The global cell transfection market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2026 to 2035.
December 2025
The global cell and gene supply chain services market size is expected to hit over USD 4.65 billion by 2035 from USD 1.75 billion in 2025, with CAGR of 10.27%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
December 2025
The global electric and fuel cell truck market size is projected to hit around USD 154.30 billion by 2035 from USD 5.45 billion in 2025, with a CAGR of 39.70%.
September 2025
The global autologous stem cell and non-stem cell based therapies market size is estimated to hit around USD 25.78 billion by 2034 increasing from USD 8.64 billion in 2024, with a CAGR of 11.55%.
August 2025
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
July 2025
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 548.55 million in 2024, with a CAGR of 7.34%.
July 2025
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 11.60 billion in 2024, with a CAGR of 26.62%.
July 2025
The cell and gene therapy infrastructure market is expanding with scalable manufacturing, integrated delivery networks, and advanced clinical site readiness.
July 2025
Explore the cell and gene therapy patient access and reimbursement Market, driven by evolving payer policies, value-based care models, and rising adoption of high-cost cell and gene therapies.
July 2025
The global FFPE tissue samples for genomics study and analysis market size is estimated to hit around USD 1,548.29 million by 2034 from USD 937.04 million in 2024, with a CAGR of 5.15%.
July 2025
The global tissue expanders market size was valued at USD 747.47 million in 2024 and is expected to attain around USD 1,385.63 million by 2034 with a CAGR of 6.37%.
June 2026
The global tissue dissociation market size was estimated at USD 354.16 million in 2025 and is expected to hit around USD 799.97 million by 2035, growing at a CAGR of 8.49%.
June 2026
The global induced pluripotent stem cell (iPSC) therapy market is driven by rising chronic disease prevalence, personalized medicine demand, and advances in regenerative technology.
June 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 317.35 billion in 2025 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
June 2026
The global cell encapsulation technology market is growing as regenerative medicine and cell therapies adopt protective encapsulation techniques.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global in vivo cell reprogramming market is expanding as regenerative medicine advances toward direct in-body cell conversion for tissue repair and disease treatment.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global human primary cell culture market size was estimated at USD 4.33 billion in 2025 and is expected to hit around USD 12.21 billion by 2035, growing at a CAGR of 10.92% from 2026 to 2035.